F2R and chronic obstructive pulmonary disease: PAR-1 (ATAP-2) immunoreactivity (cells/mm) of epithelial cells showed higher levels in the central (p < 0.005) and distal airways (p < ns) of COPD patients compared to HC subjects (Figure 1A,B).